Issue 4/2002
Content (13 Articles)
The effects of food on the pharmacokinetic profile of oral vinorelbine
Roland Bugat, Philippe Variol, Henri Roché, Pierre Fumoleau, Gilles Robinet, Isabelle Senac
Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells
John Andrews, Daniel Djakiew, Scott Krygier, Peter Andrews
Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of a randomized trial with epirubicin comparing short-term versus long-term maintenance treatment
Koichiro Nomata, Mitsuru Noguchi, Hiroshi Kanetake, Nobuo Tsuda, Mikio Hayashi, Shuji Yamashita, Tsutomu Sakuragi, Yasuyuki Kusaba, Kazuhiko Shindo
Phage-displayed random peptide libraries in mice: toxicity after serial panning
David N. Krag, Susan P. Fuller, Lyn Oligino, Stephanie C. Pero, Donald L. Weaver, Amy L. Soden, Christopher Hebert, Sadie Mills, Chen Liu, Daniel Peterson
Therapeutic advantage from combining 5-fluorouracil with the hypoxia-selective cytotoxin NLCQ-1 in vivo; comparison with tirapazamine
M. Papadopoulou, M. Ji, X. Ji, W. Bloomer
Folinic acid, 5-fluorouracil and mitomycin C in metastatic breast cancer patients previously treated with at least two chemotherapy regimens
Guido Francini, Roberto Petrioli, Simona Messinese, Daniele Pozzessere, Stefania Marsili, Pierpaolo Correale, Marianna Sabatino, Anna Fiaschi
Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats
Bernhard Erdlenbruch, Verena Jendrossek, Wilfried Kugler, Hansjörg Eibl, Max Lakomek
Pharmacokinetics of ecteinascidin 743 administered as a 24-h continuous intravenous infusion to adult patients with soft tissue sarcomas: associations with clinical characteristics, pathophysiological variables and toxicity
Thomas A. Puchalski, David P. Ryan, Rocio Garcia-Carbonero, George D. Demetri, Leah Butkiewicz, David Harmon, Michael V. Seiden, Robert G. Maki, Luis Lopez-Lazaro, Jose Jimeno, Cecilia Guzman, Jeffrey G. Supko
Preclinical toxicity studies of kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat
Alan P. Brown, Robert L. Morrissey, Glynn T. Faircloth, Barry S. Levine
Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed
Nancy L. Lewis, Richard Scher, James M. Gallo, Paul F. Engstrom, Christine E. Szarka, Samuel Litwin, Andrea L. Adams, Deborah Kilpatrick, Diane Brady, Louis M. Weiner, Neal J. Meropol
Preoperative cisplatin for initial treatment of limb osteosarcoma: its local effect and impact on prognosis
S. Abe, Y. Nishimoto, K. Isu, T. Ishii, T. Goto
Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen)
Eveline Boucher, Stéphane Corbinais, Pierre Brissot, Karim Boudjema, Jean-Luc Raoul
Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles
Iwao Iwasaki, Hisahiko Sugiyama, Shinsaku Kanazawa, Hiromichi Hemmi